LPAR—substituted cyanopyrazole compounds

摘要

Provided herein are compounds of the formula (I), as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of inflammatory diseases and disorders such pulmonary fibrosis.;

主权项

1. A compound of formula (I): wherein: R1 is lower alkyl or cycloalkyl; and R2 is phenyl, unsubstituted or mono-, bi- or tri-substituted independently with alkoxy, phenyl alkoxy, lower alkyl or halogen; naphthalenyl, unsubstituted or substituted with alkoxy; or indenyl, unsubstituted or substituted with alkoxy; or a pharmaceutically acceptable salt thereof.